Aug 27, 2026
1:5
For every 5 shares held, investors received 1. The price per share adjusted from $1.29 to $6.45.
The split itself did not change the total investment value.
Interpace Biosciences, Inc. (GETTEX:PF42) operates in the Medical specialties industry.
Interpace Biosciences, Inc. company overviewInterpace Biosciences, Inc.'s most recent stock split was on August 27, 2026. It was a 1-for-5 reverse split, so shareholders received 1 share for every 5 they held.
Interpace Biosciences, Inc. (GETTEX:PF42) has split its stock 3 times: a 1-for-10 reverse split on December 29, 2016, a 1-for-10 reverse split on January 15, 2020, and a 1-for-5 reverse split on August 27, 2026.
Interpace Biosciences, Inc. has split its stock 3 times. This history records 3 reverse splits between December 29, 2016 and August 27, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Interpace Biosciences, Inc.'s 1-for-5 reverse split on August 27, 2026, every 5 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Interpace Biosciences, Inc. has not announced a new split in our records. Its most recent split was on August 27, 2026, less than a year ago. Companies announce splits in advance, and any new GETTEX:PF42 split will appear on this page.